MOGAMULIZUMAB
UNII YI437801BE

Substance Identification & Data

This profile provides standardized clinical and technical data for Mogamulizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YI437801BE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1159266-37-1 and the RxNorm Concept ID (RxCUI) 2054068. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YI437801BE

CAS Registry Number

1159266-37-1

RxNorm Concept ID

2054068

Detailed Substance Profile

Preferred Name

MOGAMULIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

YI437801BE

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C62510

National Cancer Institute reference terminology for clinical and research data.

INN ID

9374

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-20

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mogamulizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MOGAMULIZUMAB

MOGAMULIZUMAB-KPKC

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(CC CHEMOKINE RECEPTOR CCR4) (HUMAN-MOUSE MONOCLONAL KW-0761 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL KW-0761 .KAPPA.-CHAIN, DIMER

MOGAMULIZUMAB (GENETICAL RECOMBINATION)

MOGAMULIZUMAB (GENETICAL RECOMBINATION) [JAN]

MOGAMULIZUMAB [INN]

MOGAMULIZUMAB [JAN]

MOGAMULIZUMAB [MI]

MOGAMULIZUMAB [USAN]

MOGAMULIZUMAB [WHO-DD]

MOGAMULIZUMAB KPKC [WHO-DD]

MOGAMULIZUMAB-KPKC [PURPLE BOOK CDER]